 - Chronic lymphocytic leukemiasmall lymphocytic lymphoma CLLSLL, marginal zone B-cell lymphoma or follicular lymphoma that have progressed after at least two prior therapies. Patients with bulky disease nodal mass greater than 5 cm. 